Bolden Therapeutics is a biotechnology company focused on creating innovative therapeutics aimed at treating central nervous system diseases. The company is developing a unique therapeutic compound designed to activate a crucial molecular pathway that promotes the generation of new neurons in the adult brain. This approach seeks to address neurodegenerative conditions, including Alzheimer's disease and ischemic stroke, with the goal of improving patient outcomes and enhancing quality of life for those affected by these challenging disorders.
Haus is a beverage brand creating better products for the modern drinker. Haus is taking on the American liquor industry, which hasn’t changed since prohibition. Through products made with only natural ingredients, new approaches to distribution, and transparent processes, Haus is building a business holistically designed in the best interests of today’s consumer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.